Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure–Activity Relationship Study of Cannabidiol-Based Analogs as Negative Allosteric Modulators of the μ-Opioid Receptor
Taryn Bosquez-Berger, Jessica A. Gudorf, Charles P. Kuntz, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9466-9494
Closed Access | Times Cited: 12

Showing 12 citing articles:

Recent developments in molecular modeling tools and applications related to pharmaceutical and biomedical research
Paola Peluso, Bezhan Chankvetadze
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 238, pp. 115836-115836
Open Access | Times Cited: 17
Advances, opportunities, and challenges in methods for interrogating the structure activity relationships of natural products
Christine Mae F. Ancajas, Abiodun S. Oyedele, Caitlin M. Butt, et al.
Natural Product Reports (2024) Vol. 41, Iss. 10, pp. 1543-1578
Open Access | Times Cited: 7
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Claire Alexander, Jiyoon Jeon, Kyle Nickerson, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116742-116742
Closed Access
Advances in the structural understanding of opioid allostery
Nokomis Ramos‐Gonzalez, Balázs R. Varga, Susruta Majumdar
Trends in Pharmacological Sciences (2025)
Open Access
Endogenous opiates and behavior: 2023
Richard J. Bodnar
Peptides (2024) Vol. 179, pp. 171268-171268
Closed Access | Times Cited: 4
CBD Versus CBDP: Comparing In Vitro Receptor-Binding Activities
Mehdi Haghdoost, Scott Young, Alisha K. Holloway, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7724-7724
Open Access | Times Cited: 2
IUPHAR review: Recent progress in the development of Mu opioid receptor modulators to treat opioid use disorders
Piyusha P. Pagare, Rachael Flammia, Yan Zhang
Pharmacological Research (2023) Vol. 199, pp. 107023-107023
Open Access | Times Cited: 6
Pharmacological and morphological features and socioeconomic aspects of cannabidiol: A literature review
Oles-Pylyp Hasiuk
International Journal of Medicine and Medical Research (2023), pp. 47-59
Open Access | Times Cited: 4
Proof of Concept for High-Dose Cannabidiol Pretreatment to Antagonize Opioid Induced Persistent Apnea
Beth M. Wiese, Evgeny Bondarenko, Jack L. Feldman
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Organocatalytic Enantioselective Syntheses of Flavonoids and Cannabinoids
Andreu Vidal‐Albalat, Bruno Matos Paz
Advanced Synthesis & Catalysis (2023) Vol. 366, Iss. 5, pp. 1032-1043
Closed Access
Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor
Iu Raïch, Jaume Lillo, Carlos Ferreiro‐Vera, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17500-17500
Open Access

Ibrahim Bechri, Ali Derkaoui, Abdelkarim Shimi, et al.
International Journal of Medicine and Medical Research (2023) Vol. 9, Iss. 1
Open Access
Page 1

Scroll to top